Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long‐term followup

To report a single-center experience with the use of tumor necrosis factor (TNF) inhibitors in patients with Takayasu arteritis (TA).We retrospectively studied a cohort of patients with refractory TA evaluated at our institution and treated with TNF inhibitors. American College of Rheumatology criteria for TA were used for inclusion. Disease activity was assessed according to the National Institutes of Health criteria.We included 20 patients (19...